AlloSource Distributes First Bioengineered Blood Vessels For Humacyte Phase III Clinical Trial


Centennial, Colo. — May 23, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the distribution of investigational bioengineered blood…